Trecy Gonçalves, Cardiologist in Lariboisière-Saint Louis Hospital, shared a post on LinkedIn:
“Magnificent session Late-Breaking Clinical Science in Cardio-Oncology!
Thank you to all authors who conducted high-quality studies and trials in Cardio-Oncology, we definitely need it!
- Joe-Elie Salem and co-authors with new risk score in ICI-myocarditis
- Torbjorn Omland and co-authors with PRADA-II studying Valsartan-Sacubitril in prevention of cardiac dysfunction in breast cancer patients
- Dr Szczepaniak and co-authors highlights on vascular toxicity of docetaxel and the influence of menopause
- Dr Anker and co-authors for the hashtag#EMPATICC trial, important and realistic study on optimized heart failure treatment in patients with terminal cancer
- Pr Ky and co-authors evaluating BNP-guide strategy for heart failure treatment.”
